CH2, 47.3 (CH2–P, d, JCP 76), 70.1, 70.9; CH3, 39.3 (NCH3),
56.3 (OCH3); δP(CDCl3) 31.5; m/z (MHϩ) 696.
due was then dissolved in anhydrous MeOH (20 mL) and the
solution was treated with ammonium formate (0.66 g, 10.5
mmol) and Pd/C (10%, 20 mg). The resultant reaction mixture
was refluxed for 30 min. MeOH was removed under vacuum
and the crude product was dissolved in CH2Cl2 (30 mL),
washed with water (10 mL) and dried (Na2SO4). Concentration
under vacuum left an oily residue and final recrystallization
from EtOH afforded the desired natural product 1 (0.185 g,
70% after recrystallization) or 2 (0.173 g, 65% after recrystal-
lization). The analytical and spectral data of synthetic 1 and 2
matched those reported for the natural products.
N-Diphenyphosphinoylmethyl-N-methyl-2-(4-benzyloxy-
benzoyl)-4-methoxy-3-benzyloxybenzamide 9. White crystals
(1.22 g, 82%), mp 83–84 ЊC (Found: C, 74.05; H, 5.45; N, 1.95.
C43H38NO6P requires C, 74.2; H, 5.5; N, 2.0%); νmax(KBr)/cmϪ1
1639 (CO), 1633 (CO), 1170 (PO); δH(CDCl3) 3.15 (3 H, s,
NCH3), 3.87 (3 H, s, OCH3), 4.47 (2 H, br s, NCH2P), 4.84 (2 H,
s, OCH2Ph), 5.08 (2 H, s, OCH2Ph), 6.82 (1 H, d, J 8.5, Harom),
6.92 (2 H, d, J 8.7, Harom), 6.95–7.53 (18 H, m, Harom), 7.71 (2 H,
d, J 8.7, Harom), 7.85–7.89 (3 H, m, Harom); δC(CDCl3) C, 125.3,
130.9 (Carom–P, d, JCP 98), 134.0, 136.3, 136.7, 153.4 (C–O),
Acknowledgements
162.9 (C–O), 169.8 (NC᎐O), 193.9 (C᎐O); CH, 112.5, 114.4,
᎐
᎐
122.7, 127.4, 127.8, 128.1 (d, JCP 13.5), 128.2, 128.3, 128.7 (d,
JCP 9), 129.0, 131.1 (d, JCP 10), 132.1 (d, JCP 13.5); CH2, 47.1
(CH2–P, d, JCP 75), 70.1, 75.4; CH3 39.4 (NCH3), 56.0 (OCH3);
δP(CDCl3) 31.5; m/z (MHϩ) 696.
We are grateful to the ‘Centre National de la Recherche
Scientifique’ and the Ministère de l’Enseignement Supérieur et
de la Recherche for a financial support (grant to S. L.). We
would like also to thank G. Bird (Zeneca Pharma, Reims) for
helpful comments on the manuscript.
General procedure for the synthesis of 4-aryl-1(2H)-isoquinol-
ones 6 and 7
References
A solution of KHMDS (1.5 mL, 0.75 mmol, 0.5 in toluene)
was added dropwise to a stirred solution of parent amide 8 or 9
(0.5 g, 0.72 mmol) in THF (30 mL) at Ϫ78 ЊC under Ar. The
solution was stirred for 30 min at Ϫ78 ЊC after which it was
warmed to room temperature and stirred for an additional 30
min. After this, several drops of dilute HCl (10%), water (10
mL), Et2O (20 mL) and CH2Cl2 (20 mL) were added to the
reaction mixture. The organic layer was separated, rinsed with
brine, dried (MgSO4) and concentrated to dryness. The crude
products were purified by flash column chromatography using
AcOEt–hexanes (60:40) as eluent and finally recrystallized
from hexane–toluene.
1 A. Brossi, G. Grethe, S. Tertel, S. C. Wildman and D. T. Bailey,
J. Org. Chem., 1970, 36, 1100.
2 S. Kobayashi, T. Tokumoto and Z. Taira, J Chem. Soc., Chem.
Commun., 1984, 1043.
3 C. Fuganti, in The Alkaloids, ed. R. H. F. Manske, Academic Press,
New York, 1975, vol. XV, p. 139.
4 M. Shamma and J. L. Moniot, Isoquinoline Alkaloids Research
1972–1977, Plenum Press, New York, 1978, p. 389.
5 F. A. Kincl, V. Troncoso and G. Rosenkranz, J. Org. Chem., 1957,
22, 574.
6 T. Kametani, The Chemistry of the Isoquinoline Alkaloids, The
Sendai Institute of Heterocyclic Chemistry, Sendai, 1974, vol. 2,
p. 321.
7 H. Hara, R. Shirai, O. Hoshino and B. Umezawa, Heterocycles,
1983, 20, 1945 and references cited therein.
4-(4-Benzyloxyphenyl)-6-methoxy-7-benzyloxy-1(2H)-iso-
quinolone 6. White crystals (0.29 g, 85%), mp 168–169 ЊC
(Found: C, 77.8; H, 5.65; N, 3.0. C31H27NO4 requires C, 78.0; H,
5.7; N, 2.9%); νmax(KBr)/cmϪ1 1645 (CO); δH(CDCl3) 3.60 (3 H,
s, NCH3), 3.80 (3 H, s, OCH3), 5.12 (2 H, s, OCH2Ph), 5.27
(2 H, s, OCH2Ph), 6.90 (2 H, s, Harom), 7.07 (2 H, d, J 8.5, Harom),
7.27–7.51 (12 H, m, Harom), 7.96 (1 H, s, Harom); δC(CDCl3)
C, 118.6, 119.8, 129.2, 132.2, 136.5, 136.8, 148.2 (C–O), 153.5
8 Annual Reports in Medicinal Chemistry, ed. H.-J. Hess, Academic
Press, New York, 1978, vol. 13, p. 6; 1978, vol. 14, p. 1; 1981, vol. 16,
p. 89 and references cited therein.
9 J. D. Kohli and L. I. Goldberg, J. Pharm. Pharmacol., 1980, 32, 225.
10 J. A. Poat, G. N. Woodruff and K. J. Watling, J. Pharm. Pharmacol.,
1978, 30, 495.
11 B. Costall and R. J. Naylor, J. Pharm. Pharmacol., 1978, 30, 514.
12 J. N. Jacob, D. E. Nichols, J. D. Kohli and D. Glock, J. Med. Chem.,
1981, 24, 1013.
13 (a) M. A. Schwartz and S. W. Scott, J. Org. Chem., 1971, 36, 1827;
(b) T. Kametani, K. Takahashi and C. V. Lock, Tetrahedron, 1975,
31, 235; (c) D. J. Hart, P. A. Cain and D. A. Evans, J. Am. Chem.
Soc., 1978, 100, 1548; (d) H. Irie, A. Shiina, T. Fushimi,
J. Katakawa, N. Fujii and H. Yajima, Chem. Lett., 1980, 875; (e)
T. Kametani, K. Higashiyama, T. Honda and H. Otomasu, J. Chem.
Soc., Perkin Trans. 1, 1982, 2935; ( f ) J. Katakawa, H. Yoshimatsu,
M. Yoshida, Y. Zhang, H. Irie and H. Yasima, Chem. Pharm. Bull.,
1988, 36, 3928.
14 S. Kobayashi, T. Tokumoto, S. Iguchi, M. Kihara, Y. Imakura and
Z. Taira, J. Chem. Res. (S), 1986, 280; J. Chem. Res. (M), 1986, 2444.
15 A Brossi and S. Tertel, Tetrahedron Lett., 1970, 417.
16 T. Nomoto, N. Nasui and H. Takayama, J. Chem. Soc., Chem.
Commun., 1984, 1646.
(C–O), 158.4 (C–O), 161.4 (NC᎐O); CH, 105.3, 109.8, 115.0,
᎐
127.5, 127.6, 128.0, 128.1, 128.5, 128.6, 130.1 (CH᎐), 130.9;
᎐
CH2, 70.1, 70.8; CH3, 37.0 (NCH3), 55.9 (OCH3); m/z (MHϩ)
478.
4-(4-Benzyloxyphenyl)-6-methoxy-5-benzyloxy-1(2H)-iso-
quinolone 7. White crystals (0.28 g, 82%), mp 204–205 ЊC
(Found: C, 78.05; H, 5.6; N, 3.2. C31H27NO4 requires C, 78.0; H,
5.7; N, 2.9%); νmax(KBr)/cmϪ1 1644 (CO); δH(CDCl3) 3.58 (3 H,
s, NCH3), 3.92 (3 H, s, OCH3), 4.30 (2 H, s, OCH2Ph), 4.98
(2 H, s, OCH2Ph), 7.18–7.47 (11 H, m, Harom), 8.38 (1 H, d,
J 8.9, Harom); δC(CDCl3) C, 116.5, 120.7, 131.4, 132.0, 136.9,
137.2, 142.3 (C–O), 156.0 (C–O), 158.0 (C–O), 161.8 (NC᎐O);
CH, 112.1, 113.7, 125.6, 127.5, 127.6, 127.8, 128.0, 128.3, 128.6,
17 S. Takano, M. Akiyama, K. Ogasawara, J. Chem. Soc., Perkin
Trans. 1, 1985, 2447.
᎐
18 (a) A. Couture, E. Deniau and P. Grandclaudon, Tetrahedron Lett.,
1993, 34, 1479; (b) B. H. Bakker, D. S. Tjin A-Lim and A. van der
Gen, Tetrahedron Lett., 1984, 25, 4259; (c) A. Couture, E. Deniau
and P. Grandclaudon, Tetrahedron, 1997, 53, 10303; (d) A. Couture,
E. Deniau, C. Hoarau and P. Grandclaudon, J. Org. Chem., 1998,
63, 3128.
130.9, 133.8 (CH᎐); CH , 70.1, 75.4; CH , 36.6 (NCH ), 56.0
᎐
2
3
3
(OCH3); m/z (MHϩ) 478.
General procedure for the synthesis of the targeted ( )-cherylline
1 and ( )-latifine 2
19 (a) A. Couture, E. Deniau, Y. Gimbert and P. Grandclaudon,
J. Chem. Soc., Perkin Trans. 1, 1993, 2463; (b) A. Couture, E.
Deniau, P. Grandclaudon and P. Woisel, Tetrahedron, 1996, 52,
4433.
20 S. Horne and R. Rodrigo, J. Chem. Soc., Chem. Commun., 1992,
164.
21 W. E. Parham and Y. A. Sayed, J. Org. Chem., 1974, 39, 2053.
22 W. P. Griffith and S. V. Ley, Aldrichim. Acta, 1990, 23, 13.
23 B. S. Bal, W. E. Childers and H. W. Pinnick, Tetrahedron, 1981, 37,
2091.
A solution of isoquinolone 6 or 7 (500 mg, 1.05 mmol) in
anhydrous THF (20 mL) was treated with LiAlH4 (250 mg, 5.25
mmol) added portionwise at 0 ЊC under Ar over a period of 30
min. The resultant mixture was stirred at 0 ЊC for an additional
30 min then warmed to room temperature and gently refluxed
for 2 h. The excess of hydride was destroyed by careful addition
of EtOH, the reaction mixture was filtered on Celite and the
solvents were subsequently removed under vacuum. The resi-
J. Chem. Soc., Perkin Trans. 1, 1999, 789–794
793